The Role of BRD4 in Cardiac Specification
BRD4 在心脏指标中的作用
基本信息
- 批准号:10394203
- 负责人:
- 金额:$ 40.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdoptionAreaBindingBromodomainCardiacCardiac MyocytesCardiac developmentCardiovascular DiseasesCause of DeathCell Differentiation processCell TherapyCellsChIP-seqChemicalsComplexCongestive Heart FailureCuesDataDevelopmentEmbryoEndotheliumFamily memberFlow CytometryFoundationsGene ActivationGene ExpressionGenesGeneticGenetic TranscriptionGenomeGoalsHeartHeart failureHistonesHumanImmunohistochemistryIn VitroLaboratoriesLysineModelingModificationMolecularMusMuscle CellsMyocardiumNucleic Acid Regulatory SequencesPathway interactionsPatientsPregnancyProcessProteinsReaderReadingRegulator GenesRegulatory ElementRepressionRoleSeriesShapesSmooth Muscle MyocytesTertiary Protein StructureTestingTissuesUnited StatesWorkcardiogenesiscell regenerationcell typeembryonic stem cellexperimental studyfetalfield studyin vivoinsightinterestmouse modelmutantmyogenesisnovel therapeuticsprogenitorprogramsprotein functionregenerativeregenerative approachregenerative therapystem cellstumor progression
项目摘要
Summary Statement
Cardiovascular disease remains the leading cause of death in the United States. One emerging long-term
strategy for patients with congestive heart failure focuses on cellular regeneration. Efforts include boosting the
function of existing cardiac myocytes, introducing immature myocytes into failing hearts, and even introducing
electrically insulated patches of myocardium. All of these efforts require a highly-detailed understanding of the
molecular determinants that drive myocyte lineage specification and differentiation and the mechanistic basis
by which these factors regulate lineage specific gene expression cascades. Landmark studies have revealed a
critical role for the Bromodomain extraterminal domain (BET) protein Brd4 in regulating lineage specific gene
programs by recognizing or reading areas of the genome marked by specific modifications. In addition, studies
abrogating BET protein function in murine models of heart failure have demonstrated promising results, by
modulating lineage specific function. However, the normal role of BET proteins, specifically Brd4, has not been
elucidated during cardiac development. Our data implicates a critical role for Brd4 during cardiac development,
specifically by transcriptionally activating genes poised for expression upon lineage adoption. We seek to
define the exact programs activated by Brd4 during cardiac development. In addition, our studies seek to
understand if cardiac progenitor cells are rendered vulnerable to adopting aberrant cell fates upon loss of
activation cues (via loss of Brd4). Our work will provide essential insight into how Brd4 drives cardiac lineage
specification, ultimately allowing for manipulation of this process to generate cell types of interest. Defining the
molecular pathways which regulate myogenesis will undoubtedly shape emerging novel therapeutics and
regenerative strategi
摘要声明
心血管疾病仍然是美国死亡的主要原因。长期出现的一项
充血性心力衰竭患者的策略集中在细胞再生上。努力包括提高
现有心肌细胞的功能,将未成熟的心肌细胞引入失败的心脏,甚至引入
心肌的电绝缘斑块。所有这些努力都需要对
驱动心肌谱系规范和分化以及机械基础的分子决定因素
这些因素调节特定基因表达级联。地标研究表明
溴结构域外部元素(BET)蛋白BRD4在调节谱系特定基因中的关键作用
通过以特定修改为标志的基因组的程序或阅读区域。另外,研究
在心力衰竭的鼠模型中,废除BET蛋白功能已证明了有希望的结果
调节谱系特定功能。但是,BET蛋白(特别是BRD4)的正常作用尚未是
在心脏发展过程中阐明。我们的数据暗示BRD4在心脏发展过程中的关键作用,
特别是通过转录激活基因在谱系采用后表达的基因。我们寻求
定义心脏发育过程中BRD4激活的确切程序。此外,我们的研究试图
了解心脏祖细胞是否容易在损失后容易采用异常细胞的命运
激活提示(通过BRD4的丢失)。我们的工作将提供有关BRD4如何驱动心脏血统的基本见解
规范,最终允许操纵此过程以产生感兴趣的细胞类型。定义
调节肌发生的分子途径无疑会塑造新的新型治疗剂和
再生策略
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure Pathogenesis.
染色质重塑驱动心力衰竭发病机制中的免疫成纤维细胞串扰。
- DOI:10.1101/2023.01.06.522937
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Alexanian,Michael;Padmanabhan,Arun;Nishino,Tomohiro;Travers,JoshuaG;Ye,Lin;Lee,ClaraYoungna;Sadagopan,Nandhini;Huang,Yu;Pelonero,Angelo;Auclair,Kirsten;Zhu,Ada;Teran,BarbaraGonzalez;Flanigan,Will;Kim,CharisKee-Seon;Lumbao-C
- 通讯作者:Lumbao-C
Landscape of Hopx expression in cells of the immune system.
- DOI:10.1016/j.heliyon.2021.e08311
- 发表时间:2021-11
- 期刊:
- 影响因子:4
- 作者:Bourque J;Opejin A;Surnov A;Iberg CA;Gross C;Jain R;Epstein JA;Hawiger D
- 通讯作者:Hawiger D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajan Jain其他文献
Rajan Jain的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajan Jain', 18)}}的其他基金
Deciphering how 3D genome organization orchestrates cardiac cellular identity
解读 3D 基因组组织如何协调心脏细胞身份
- 批准号:
10574267 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
- 批准号:
10116703 - 财政年份:2020
- 资助金额:
$ 40.25万 - 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
- 批准号:
10473778 - 财政年份:2020
- 资助金额:
$ 40.25万 - 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
- 批准号:
10268225 - 财政年份:2020
- 资助金额:
$ 40.25万 - 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
- 批准号:
10684727 - 财政年份:2020
- 资助金额:
$ 40.25万 - 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
- 批准号:
10248408 - 财政年份:2019
- 资助金额:
$ 40.25万 - 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
- 批准号:
10461144 - 财政年份:2019
- 资助金额:
$ 40.25万 - 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
- 批准号:
10020996 - 财政年份:2019
- 资助金额:
$ 40.25万 - 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
- 批准号:
9790532 - 财政年份:2019
- 资助金额:
$ 40.25万 - 项目类别:
Investigating the role of Hopx in cardiac progenitor proliferation
研究 Hopx 在心脏祖细胞增殖中的作用
- 批准号:
8566353 - 财政年份:2013
- 资助金额:
$ 40.25万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 40.25万 - 项目类别:
Testing and Texting in Community Health Center Dental Clinics to Diagnose and Prevent HIV Infection
在社区健康中心牙科诊所进行检测和发短信以诊断和预防艾滋病毒感染
- 批准号:
10864322 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Crossroads: Using decision making strategies to develop high impact content for training in rigor and transparency.
十字路口:使用决策策略来开发高影响力的内容,以进行严格和透明的培训。
- 批准号:
10722510 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias
年度健康就诊政策:对患有阿尔茨海默病及其相关痴呆症的医疗保险受益人的早期痴呆诊断和医疗质量差异的影响
- 批准号:
10729272 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别: